This article is more than 5 years old. Information may no longer be current.

Inotek reports $10.7 million first-quarter net loss

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Inotek Pharmaceuticals reported a $10.7 million net loss in the first quarter of 2017 compared with a $10.1 million net loss in 2016’s first quarter, according to a press release.

Research and development costs decreased from $7.6 million in the first quarter of 2016 to $7.1 million, whereas general and administrative costs increased from $2.5 million to $2.9 million.

Cash, cash equivalents and short-term investments totaled $114.7 million as of March 31.